Cargando…

Prognostic factors of patients with small cell lung cancer after surgical treatment

BACKGROUND: The current National Comprehensive Cancer Network guidelines recommend surgical treatment for patients with stages I–IIA small cell lung cancer (SCLC), but it still cannot deny the effect of surgical treatment on other limited-stage SCLC. Although more advanced diagnostic methods are now...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Cheng, Li, Nana, Li, Feng, Zhang, Peng, Wu, Kai, Liu, Donglei, Zhao, Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350721/ https://www.ncbi.nlm.nih.gov/pubmed/34430587 http://dx.doi.org/10.21037/atm-21-2912

Ejemplares similares

Prognostic factors and outcome of surgically treated patients with brain metastases of non‐small cell lung cancer
por: She, Chunhua, et al.
Publicado: (2018)

Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer
por: Hu, Yan, et al.
Publicado: (2021)

Advanced Lung Cancer Inflammation Index is a Prognostic Factor of Patients with Small-Cell Lung Cancer Following Surgical Resection
por: Hu, Zhonghui, et al.
Publicado: (2021)

Evaluation of prognostic factors in lung cancers with surgical complete response after induction treatment
por: Doğru, Mustafa Vedat, et al.
Publicado: (2021)

The prognostic value of the Naples prognostic score for patients with non-small-cell lung cancer
por: Peng, Si-Min, et al.
Publicado: (2022)

Prognostic Nomogram of Osteocarcinoma after Surgical Treatment
por: Wu, Qiuli, et al.
Publicado: (2022)

Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer
por: Satoh, Hiroaki, et al.
Publicado: (2022)

Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer
por: Moskalenko, Yuliia, et al.
Publicado: (2022)

Prognostic significance of PD-L1 in advanced non-small cell lung carcinoma
por: Zhao, Yanjie, et al.
Publicado: (2020)

The role of adjuvant chemotherapy after neoadjuvant chemotherapy or chemoradiotherapy plus esophagectomy in patients with esophageal cancer: a retrospective cohort study
por: He, Hongbo, et al.
Publicado: (2022)

The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: a systematic review and meta-analysis
por: Li, Wen-Ya, et al.
Publicado: (2019)

Prognostic value of molecular events from negative surgical margin of non-small-cell lung cancer
por: Cao, Bangrong, et al.
Publicado: (2016)

Long noncoding RNA PART1 promotes progression of non‐small cell lung cancer cells via JAK‐STAT signaling pathway
por: Zhu, Dengyan, et al.
Publicado: (2019)

Development and validation of two prognostic nomograms for predicting survival in patients with non-small cell and small cell lung cancer
por: Xiao, Hai-Fan, et al.
Publicado: (2017)

Clinical prognostic factors in surgically treated oligometastatic non-small cell lung cancer: a systematic review
por: Bertolaccini, Luca, et al.
Publicado: (2021)

Prognostic and clinicopathological significance of Beclin-1 in non-small-cell lung cancer: a meta-analysis
por: Zheng, Tianliang, et al.
Publicado: (2018)

Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer
por: Sonehara, Kei, et al.
Publicado: (2020)

Expression of TARBP1 protein in human non-small-cell lung cancer and its prognostic significance
por: Ye, Jingmei, et al.
Publicado: (2018)

Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer
por: Lin, Gen, et al.
Publicado: (2017)

Clinicopathological features and prognostic implications of ASCL1 expression in surgically resected small cell lung cancer
por: Wei, Jiacong, et al.
Publicado: (2020)

Risk factors for brain metastases after prophylactic cranial irradiation in small cell lung cancer
por: Zeng, Haiyan, et al.
Publicado: (2017)

Prognostic value of chemotherapy-induced leukopenia in small-cell lung cancer
por: Liu, Wei, et al.
Publicado: (2013)

Surgical treatment in non-small cell lung cancer with pulmonary oligometastasis
por: He, Jinyuan, et al.
Publicado: (2017)

ANKRD29, as a new prognostic and immunological biomarker of non–small cell lung cancer, inhibits cell growth and migration by regulating MAPK signaling pathway
por: Zhao, Hanqing, et al.
Publicado: (2023)

Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma
por: Cai, Mu-Yan, et al.
Publicado: (2016)

Prognostic factors and nomogram for cancer-specific death in non small cell lung cancer with malignant pericardial effusion
por: Hu, Zhi Gang, et al.
Publicado: (2019)

Poor Prognostic Factors in Surgically Resected Stage I Non-small Cell Lung Cancer: Histopathologic and Immunohistochemical Analysis
por: Cho, Sukki, et al.
Publicado: (2012)

NUF2 Is a Potential Immunological and Prognostic Marker for Non-Small-Cell Lung Cancer
por: Li, Xia, et al.
Publicado: (2022)

The expression of plakoglobin is a potential prognostic biomarker for patients with surgically resected lung adenocarcinoma
por: He, Xiaobo, et al.
Publicado: (2016)

Prognostic factors associated with early mortality after surgical resection for pancreatic adenocarcinoma
por: Kwak, Bong Jun, et al.
Publicado: (2014)

Baseline anemia and anemia grade are independent prognostic factors for stage IV non-small cell lung cancer
por: Chen, Cheng, et al.
Publicado: (2021)

Prognostic Significance of the Combined Score of Endothelial Expression of Nucleolin and CD31 in Surgically Resected Non-Small Cell Lung Cancer
por: Zhao, Hongyun, et al.
Publicado: (2013)

Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer
por: Li, Wen-Cai, et al.
Publicado: (2021)

Prognostic factors, treatment, and outcomes in combined small cell lung cancer: a SEER survey from 2004 to 2015
por: Xu, Long, et al.
Publicado: (2020)

Editorial: Prognostic factors in non-small cell lung cancer
por: Rahouma, Mohamed, et al.
Publicado: (2023)

The Kinetic Changes of Systemic Inflammatory Factors during Bevacizumab Treatment and Its Prognostic Role in Advanced Non-small Cell Lung Cancer Patients
por: Li, Butuo, et al.
Publicado: (2019)

The Prognostic Role of MET Protein Expression Among Surgically Resected Non-small Cell Lung Cancer Patients: A Meta-Analysis
por: Ma, Guangzhi, et al.
Publicado: (2019)

Evaluation of prognostic factors in the surgical treatment of pulmonary metastases
por: Pawełczyk, Konrad, et al.
Publicado: (2015)

Prognostic factors and role of postoperative radiotherapy in surgically resected thymomas
por: Yang, Fujun, et al.
Publicado: (2023)

Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer
por: Jin, Ying, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fnm39djkidmm5b6vtpp57crnn6